CVS Health Corporation
CVS
$76.19
$2.012.71%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.87% | 6.66% | 6.21% | 4.75% | 3.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.87% | 6.66% | 6.21% | 4.75% | 3.93% |
| Cost of Revenue | 7.87% | 7.22% | 7.53% | 5.99% | 5.95% |
| Gross Profit | 7.88% | 3.13% | -1.67% | -2.54% | -7.56% |
| SG&A Expenses | 4.56% | 2.72% | 3.66% | 4.77% | 5.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.49% | 6.70% | 7.09% | 5.85% | 5.87% |
| Operating Income | 24.94% | 4.86% | -20.08% | -25.67% | -43.06% |
| Income Before Tax | -65.26% | -56.77% | -32.63% | -27.23% | -44.97% |
| Income Tax Expenses | -73.88% | 44.44% | -17.69% | -23.10% | -44.31% |
| Earnings from Continuing Operations | -62.32% | -91.46% | -37.69% | -28.65% | -45.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 42.86% | 583.33% | 400.00% | 224.14% | 216.67% |
| Net Income | -61.68% | -90.65% | -36.98% | -27.88% | -44.70% |
| EBIT | 24.94% | 4.86% | -20.08% | -25.67% | -43.06% |
| EBITDA | 15.92% | 3.45% | -13.94% | -18.25% | -31.62% |
| EPS Basic | -61.77% | -90.11% | -36.28% | -26.54% | -43.51% |
| Normalized Basic EPS | 25.97% | 12.87% | -14.36% | -20.53% | -40.89% |
| EPS Diluted | -62.69% | -90.29% | -36.30% | -26.40% | -43.35% |
| Normalized Diluted EPS | 25.85% | 13.01% | -14.25% | -20.40% | -40.81% |
| Average Basic Shares Outstanding | 0.64% | -0.16% | -0.90% | -1.62% | -2.08% |
| Average Diluted Shares Outstanding | 0.85% | -0.28% | -1.08% | -1.83% | -2.23% |
| Dividend Per Share | 0.00% | 2.31% | 4.72% | 7.26% | 9.92% |
| Payout Ratio | 1.63% | 9.94% | 0.65% | 0.46% | 0.95% |